Cell Reports (Jun 2017)

Dectin-1 Activation Exacerbates Obesity and Insulin Resistance in the Absence of MyD88

  • Angela Castoldi,
  • Vinicius Andrade-Oliveira,
  • Cristhiane Favero Aguiar,
  • Mariane Tami Amano,
  • Jennifer Lee,
  • Marcelli Terumi Miyagi,
  • Marcela Teatin Latância,
  • Tarcio Teodoro Braga,
  • Marina Burgos da Silva,
  • Aline Ignácio,
  • Joanna Darck Carola Correia Lima,
  • Flavio V. Loures,
  • José Antonio T. Albuquerque,
  • Marina Barguil Macêdo,
  • Rafael Ribeiro Almeida,
  • Jonas W. Gaiarsa,
  • Luis A. Luévano-Martínez,
  • Thiago Belchior,
  • Meire Ioshie Hiyane,
  • Gordon D. Brown,
  • Marcelo A. Mori,
  • Christian Hoffmann,
  • Marília Seelaender,
  • Willian T. Festuccia,
  • Pedro Manoel Moraes-Vieira,
  • Niels Olsen Saraiva Câmara

DOI
https://doi.org/10.1016/j.celrep.2017.05.059
Journal volume & issue
Vol. 19, no. 11
pp. 2272 – 2288

Abstract

Read online

The underlying mechanism by which MyD88 regulates the development of obesity, metainflammation, and insulin resistance (IR) remains unknown. Global deletion of MyD88 in high-fat diet (HFD)-fed mice resulted in increased weight gain, impaired glucose homeostasis, elevated Dectin-1 expression in adipose tissue (AT), and proinflammatory CD11c+ AT macrophages (ATMs). Dectin-1 KO mice were protected from diet-induced obesity (DIO) and IR and had reduced CD11c+ AT macrophages. Dectin-1 antagonist improved glucose homeostasis and decreased CD11c+ AT macrophages in chow- and HFD-fed MyD88 KO mice. Dectin-1 agonist worsened glucose homeostasis in MyD88 KO mice. Dectin-1 expression is increased in AT from obese individuals. Together, our data indicate that Dectin-1 regulates AT inflammation by promoting CD11c+ AT macrophages in the absence of MyD88 and identify a role for Dectin-1 in chronic inflammatory states, such as obesity. This suggests that Dectin-1 may have therapeutic implications as a biomarker for metabolic dysregulation in humans.

Keywords